Evidence map›Paper›PMID 39687257›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2024

Global challenges and solutions to achieving and sustaining measles and rubella elimination.

Natasha S Crowcroft, Anna A Minta, Sebastien Antoni, Lee Lee Ho, William Perea, Mick N Mulders, Anindya Sekhar Bose, Aaron Wallace, Diana Chang Blanc, Patrick M O'Connor

Abstract read
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Natasha S CrowcroftWorld Health Organization Geneva Switzerland World Health Organization, Geneva, Switzerland.
Anna A MintaWorld Health Organization Geneva Switzerland World Health Organization, Geneva, Switzerland.
Sebastien AntoniWorld Health Organization Geneva Switzerland World Health Organization, Geneva, Switzerland.
Lee Lee HoWorld Health Organization Geneva Switzerland World Health Organization, Geneva, Switzerland.
William PereaWorld Health Organization Geneva Switzerland World Health Organization, Geneva, Switzerland.
Mick N MuldersWorld Health Organization Geneva Switzerland World Health Organization, Geneva, Switzerland.
Anindya Sekhar BoseWorld Health Organization Geneva Switzerland World Health Organization, Geneva, Switzerland.
Aaron WallaceWorld Health Organization Geneva Switzerland World Health Organization, Geneva, Switzerland.
Diana Chang BlancWorld Health Organization Geneva Switzerland World Health Organization, Geneva, Switzerland.
Patrick M O'ConnorWorld Health Organization Geneva Switzerland World Health Organization, Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Measles and rubella have long been recognized as priorities for disease prevention because of their devastating consequences for child health; hence, all World Health Organization (WHO) regions currently have a goal to eliminate measles and four out of six WHO regions have a goal to eliminate rubella. Significant global progress has been made in the twenty-first century, with more than 40% of countries in the world verified by a Regional Verification Commission as having eliminated measles and more than 50% of countries having sustained rubella elimination. Making further progress will require addressing fundamental gaps in health systems, a particular challenge in the current global context where many countries face multiple barriers to both sustaining and achieving measles and rubella elimination. These challenges require a strategic shift toward a holistic approach that embeds immunization at the center of primary health care at all levels, which will have broad benefits beyond preventing measles and rubella. Progress will be supported through technological innovations such as microarray patch vaccines. Whether this holistic approach will be more effective than vertical initiatives at achieving measles and rubella elimination remains to be seen. Measles is so infectious and its immediate impact so visible on individuals and health systems that any weaknesses in global or national strategy are immediately evident. The tools exist to prevent every death from measles and every case of congenital rubella syndrome. Countries and partners - at all levels - share accountability for ensuring children are protected from these entirely preventable diseases.

Indexed as

disease eradicationimmunization programsMeaslesrubellavaccines

Identifiers

PMID39687257
PMCPMC11648097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.